OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 94 filers reported holding OCULAR THERAPEUTIX INC in Q1 2020. The put-call ratio across all filers is 0.20 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $225,311 | +127.3% | 43,665 | +132.1% | 0.00% | 0.0% |
| Q1 2023 | $99,134 | +28.7% | 18,811 | +21.5% | 0.00% | -50.0% |
| Q1 2022 | $77,000 | -84.5% | 15,482 | -78.3% | 0.00% | -86.7% |
| Q4 2021 | $498,000 | +72.3% | 71,455 | +105.9% | 0.02% | -76.6% |
| Q2 2020 | $289,000 | +425.5% | 34,700 | +215.5% | 0.06% | +433.3% |
| Q1 2020 | $55,000 | – | 11,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $32,263 | 100.00% |
| Opaleye Management Inc. | 6,105,900 | $32,178,093 | 9.64% |
| DELTEC ASSET MANAGEMENT LLC | 1,913,612 | $10,084,735 | 2.49% |
| Knoll Capital Management, LLC | 200,000 | $1,504,000 | 2.32% |
| Endurant Capital Management LP | 512,744 | $2,702,161 | 1.39% |
| Knoll Capital Management, LLC | 95,800 | $504,866 | 0.78% |
| Covestor Ltd | 60,008 | $316 | 0.28% |
| Ikarian Capital, LLC | 200,000 | $1,054,000 | 0.24% |
| EAM Investors, LLC | 224,211 | $1,181,592 | 0.23% |
| Nebula Research & Development LLC | 22,474 | $118,438 | 0.21% |